Picture of Euroapi SA logo

EAPI — Euroapi SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Brief: Euroapi Sees Net Sales Reaching Circa EUR 980 Mln In 2022

Dec 7 (Reuters) - Euroapi Sas  EAPI.PA :
    * EUROAPI UPDATES ITS 2022 FINANCIAL GUIDANCE
    * EUROAPI NOW ANTICIPATES NET SALES REACHING CIRCA EUR 980
MILLION
AND A CORE EBITDA MARGIN BETWEEN 12% - 13% IN 2022
    * TEMPORARY AND PROACTIVE SUSPENSION OF PROSTAGLANDIN
PRODUCTION
ACTIVITIES AT BUDAPEST SITE FOLLOWING A ROUTINE INTERNAL
ASSESSMENT
    * GROUP IDENTIFIED SOME GOOD MANUFACTURING PRACTICES
DEFICIENCIES
RELATED TO DOCUMENTATION MANAGEMENT
    * GROUP ANTICIPATES NET SALES CIRCA EUR 980 MILLION AND A
CORE
EBITDA MARGIN BETWEEN 12% - 13% IN 2022, DUE TO LOSS OF SALES,
RELATED PROVISIONS, AND REMEDIATION COSTS
    * THIS TEMPORARY AND TARGETED PAUSE OF PRODUCTION WILL
AFFECT
EUROAPI'S BUSINESS ACTIVITIES AND FINANCIAL PERFORMANCE
    * GROUP ESTIMATES THAT PROSTAGLANDIN PRODUCTION COULD REMAIN
SUSPENDED FOR A FEW WEEKS

Source text for Eikon:  ID:nBw2Bpm14a 
Further company coverage:  EAPI.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Euroapi SA

See all news